Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity

被引:45
作者
Palma, Giuseppe [1 ]
Sorice, Gian Pio [1 ]
Genchi, Valentina Annamaria [1 ]
Giordano, Fiorella [1 ]
Caccioppoli, Cristina [1 ]
D'Oria, Rossella [1 ]
Marrano, Nicola [1 ]
Biondi, Giuseppina [1 ]
Giorgino, Francesco [1 ]
Perrini, Sebastio [1 ]
机构
[1] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, I-70124 Bari, Italy
关键词
obesity; respiratory diseases; lung; adipose tissue; crosstalk; adipokines; inflammasome; NLRP3; INFLAMMASOME; LUNG-FUNCTION; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE; FAT DISTRIBUTION; INDUCED SPUTUM; SERUM LEPTIN; BODY-WEIGHT; ADIPONECTIN;
D O I
10.3390/ijms23137349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity is a chronic disease caused by an excess of adipose tissue that may impair health by altering the functionality of various organs, including the lungs. Excessive deposition of fat in the abdominal area can lead to abnormal positioning of the diaphragm and consequent reduction in lung volume, leading to a heightened demand for ventilation and increased exposure to respiratory diseases, such as chronic obstructive pulmonary disease, asthma, and obstructive sleep apnoea. In addition to mechanical ventilatory constraints, excess fat and ectopic deposition in visceral depots can lead to adipose tissue dysfunction, which promotes metabolic disorders. An altered adipokine-secretion profile from dysfunctional adipose tissue in morbid obesity fosters systemic, low-grade inflammation, impairing pulmonary immune response and promoting airway hyperresponsiveness. A potential target of these adipokines could be the NLRP3 inflammasome, a critical component of the innate immune system, the harmful pro-inflammatory effect of which affects both adipose and lung tissue in obesity. In this review, we will investigate the crosstalk between adipose tissue and the lung in obesity, highlighting the main inflammatory mediators and novel therapeutic targets in preventing pulmonary dysfunction.
引用
收藏
页数:23
相关论文
共 182 条
[1]   Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction [J].
Achari, Arunkumar E. ;
Jain, Sushil K. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
[2]   Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity [J].
Ahmad, Rasheed ;
Thomas, Reeby ;
Kochumon, Shihab ;
Sindhu, Sardar .
IMMUNITY INFLAMMATION AND DISEASE, 2017, 5 (03) :318-335
[3]   Contribution of IL-17 in Steroid Hyporesponsiveness in Obese Asthmatics Through Dysregulation of Glucocorticoid Receptors α and β [J].
Al Heialy, Saba ;
Gaudet, Mellissa ;
Ramakrishnan, Rakhee K. ;
Mogas, Andrea ;
Salameh, Laila ;
Mahboub, Bassam ;
Hamid, Qutayba .
FRONTIERS IN IMMUNOLOGY, 2020, 11 :1724
[4]   Impact of Obesity in Critical Illness [J].
Anderson, Michaela R. ;
Shashaty, Michael G. S. .
CHEST, 2021, 160 (06) :2135-2145
[5]  
[Anonymous], Safety and efficacy of oral etrasimod in adult par- ticipants with moderate-to-severe alopecia areata. clinicaltrials.gov [Internet].
[6]  
[Anonymous], SAFETY EFFICACY DAPA
[7]  
[Anonymous], GKT137831 IPF PATIEN
[8]  
[Anonymous], MITOQ TREATMENT META
[9]  
[Anonymous], Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
[10]  
[Anonymous], 2016, Federal register, V81